Advestra with syndicate banks in connection to CHF600 m Idorsia bonds

Idor­sia biopharmaceutical company has placed CHF 600 mil­lion seni­or unse­cured con­vert­ible bonds due 2028 in a private place­ment with insti­tu­tion­al investors.

The net pro­ceeds of the con­vert­ible bonds will be used to sup­port com­mer­cial product launches in sev­er­al key mar­kets and to fund the fur­ther devel­op­ment of the com­pany’s advan­cing late-stage pipeline.

Advestra acted as leg­al coun­sel to Bank of Amer­ica Mer­rill Lynch, Cred­it Suisse and Gold­man Sachs Inter­na­tion­al, who were act­ing as joint book­run­ners and Octavi­an as selling agent on the offering. Advestra team included Sandro Fehl­mann (pictured), Thomas Reut­ter and Fabi­an Loretan (all cap­it­al markets).

FabioAdmin

SHARE